Endometrioid uterine cancer: Histopathological risk factors of local and distant recurrenceToshio Fujimoto, Toshinobu Tanaka, Hiroshi Nanjyo et al.|Gynecologic Oncology|2008Cited by 112
Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancerYuko Karube, Toshinobu Tanaka, Osamu Takahashi et al.|Gynecologic Oncology|2010Cited by 25
Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)Tadahiro Shoji, Toru Sugiyama, Eriko Takatori et al.|International Journal of Gynecological Cancer|2010Cited by 18
Paclitaxel–carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit StudyTadao Takano, Junzo Kigawa, Takeo Otsuki et al.|International Journal of Clinical Oncology|2014Cited by 12
Investigation of the clinicopathological features of fallopian tube malignancyYoshihito Yokoyama, Hideki Mizunuma, Masayuki Futagami et al.|Oncology Reports|2013Cited by 5